Amgen agrees to acquire Onyx

Robert A. Bradway, chairman and chief executive of Amgen Inc., reached a deal for Onyx Pharmaceuticals Inc. and its prized cancer drug, Kyprolis.
la-fi-mo-amgen-acquires-onyx-20130825-001

( Matt Petit/Feature Photo Service / August 25, 2013 )

Robert A. Bradway, chairman and chief executive of Amgen Inc., reached a deal for Onyx Pharmaceuticals Inc. and its prized cancer drug, Kyprolis.

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook
  • Home Delivery Home Delivery

PHOTO GALLERIES

TOP VIDEO

CONNECT WITH US


2013 YEAR IN REVIEW
Look for this special section in your
Baltimore Sun newspaper on Dec. 29, 2013.
  • Twitter
  • Facebook
  • Instagram
  • Google Plus
  • RSS Feeds
  • Mobile Alerts and Apps

Contact Us | Newsroom directory | Social Sun